Skip to main content
  • 37 Accesses

Abstract

The use of positron emission tomography is of great potential in the detection of tumors. This report reviews recent studies on particular physiological and biochemical markers that appear to have a good correlation with the malignant phenotype.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Harris H, Miller OJ, Klein G, Wont P and Tachibana T (1969) Suppression of malignancy by cell fusion. Nature (Lund) 223; 363–368

    Article  CAS  Google Scholar 

  2. Jonasson J, Povey S and Harris H (1977) The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and tumours derived from them. J Cell Sci 24; 217–254

    Google Scholar 

  3. Evans EP, Burtenshaw MD, Brown BR, Hannon R and Harris H (1982) The analysis of malignancy by cell fusion. IX. Re-examination and clarification of the cytagenetic problem. J Cell Sci 56; 113–130

    Google Scholar 

  4. Weiner F, Klein G and Harris H (1971) The analysis of malignancy by cell fusion. III. Hybrids between diploid fibroblasts and other tumour cells. J Cell Sci 8; 681–692

    Google Scholar 

  5. Weiner F, Klein G and Harris H (1974) The analysis of malignancy by cell fusion. V. Further evidence of the ability of normal diploid cells to suppress malignancy. J Cell Sci 15; 177–183

    Google Scholar 

  6. Jonasson I, and Harris H (1977) The analysis of malignancy by cell fusion. VIII. Evidence for the intervention of an extra-chromosomal element. 1 Cell Sci 74; 255–263

    Google Scholar 

  7. Sager R and Kovac PE (1978) Genetic analysis of tumorigenesis. 1. Expression of tumor-forming ability in hamster hybrid cell lines. Somatic Cell Genetics 4; 375–392

    Article  PubMed  CAS  Google Scholar 

  8. Stanbridge EJ and Wilkinson 1(1978) Analysis of malignancy in human cells, malignant and transformed phenotypes are under separate genetic controL Proc Nat Acad Sci 75; 1466–1469

    Google Scholar 

  9. Klinger HP (1980) Suppression of tumorigenicity in somatic cell hybrids. I. Suppression and re-expression of tumorigenicity in diploid human x D98-AH-2 hybrids which also demonstrate independent segregation of the tumorigenic from other cell phenotypes. Cytogenet Cell Genet 27; 254–266.

    Article  PubMed  CAS  Google Scholar 

  10. Straus DS, Jonasson J and Harris H (1977) Growth in vitro of tumour cell x fibroblast hybrids in which malignancy is suppressed. J Cell Sci 25; 73–86

    PubMed  CAS  Google Scholar 

  11. Der CJ and Stanbridge EJ (1978) Lack of correlation between the decreased sion of cell surface LETS protein and tumorigenicity in human cell hybrids. Cell 15; 1241–1251

    Article  PubMed  CAS  Google Scholar 

  12. Watt FM, Harris H, Weber K and Osbom M (1978) The distribution of actin cables and micrombules in hybrids between malignant and non-malignant cells and in tumours derived from them. J Cell Sci 32; 419–432

    PubMed  CAS  Google Scholar 

  13. Bramwell ME and Hams H (1978a) An abnormal membrane glycoprotein associated with malignancy in a wide range of different tumours. Proc R Soc B 201; 87106

    Article  Google Scholar 

  14. Bramwell ME and Harris H (1978b) Some further information about the abnormal membrane glycoprotein associated with malignancy. Proc R Soc B 203; 93–99

    Article  CAS  Google Scholar 

  15. Atkinson MAL and Bramwell ME (1981) Studies on the surface properties of hybrid cells. III. A membrane glycoprotein found on the surface of a wide range of tumour cells. J Cell Sci 48; 147–170

    PubMed  CAS  Google Scholar 

  16. Bramwell ME (1980) A glycoprotein abnormality associated with malignancy. Bio-chew Soc Trans 8; 697–698

    CAS  Google Scholar 

  17. Bramwell ME and Atkinson MAL (1982) The apparent inducibility of tumour marker glycoprotein in a melanoma cell line selected for growth in law levels of glucose. 1 Cell Sci 54; 241–254

    CAS  Google Scholar 

  18. Warburg OH (1926) Ãœber den StofTwechsel der Trmoren. Berlin, Springer

    Google Scholar 

  19. Warburg OH (1956) On the origin of cancer cells. Science 123; 309–314

    Article  PubMed  CAS  Google Scholar 

  20. Huebner RI, Hatanaka M and Gilden RV (1969) Alterations in characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses. J Nall Cancer last 43; 1091–1096

    Google Scholar 

  21. White MK, Bramwell ME and Hams H (1981) Hexose transport in hybrids between malignant and normal cells. Nature Lond 294; 232–235

    Article  PubMed  CAS  Google Scholar 

  22. Salter DW and Weber M (1979) Glucose specific cytochalasin B binding is increased in chicken embryo fibroblasts transformed by Rous Sarcoma virus. J Biol Chem 254; 3554–3561

    PubMed  CAS  Google Scholar 

  23. Struck DK and Lehnaa WI (1977) Evidence for the participation of saccharidelipids in the synthesis of the oligosaccharide chain of ovalbumin. J Biol Chem 252; 1007–1013

    PubMed  CAS  Google Scholar 

  24. White MK (1982) D. Phil. Thesis, University of Oxford

    Google Scholar 

  25. Gingrich RD, Wouters M, Bramwell ME and Harris H ( 1981 a) Immunological definition in normal and malignant cells of a membrane protein involved in glucose transport. I. Preparation and properties of the antibody. J Cell Sci 52; 99–120

    Google Scholar 

  26. Gingrich RD, Wouters M, Bramwell ME and Harris H (1981 b) Immunological definition in normal and malignant cells of a membrane protein involved in glucose transport. H. Function of the antigen.] Cell Sci 52; 121–135

    Google Scholar 

  27. Ashall F, Bramwell ME and Harris H (1982) A new marker for human cancer cells. I. The Ca antigen and the Cal antibody. Lancet II; 1–6

    Google Scholar 

  28. McGee JO’D, Woods JC, Ashall F, Bramwell ME and Hams H (1982) A new marker for human cancer cells. 2. Immunohistochemical detection of the Ca antigen in human tissues with the Cal antibody. Lancet II; 7–10

    Google Scholar 

  29. Woods IC, Spriggs Al, Harris H and McGee JO’D (1982) A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Cal antibody. Lancet II; 512–514

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bramwell, M.E., White, M.K. (1984). Some Tumour Markers in Malignant and Non-Malignant Hybrid Cells. In: Knapp, W.H., Vyska, K. (eds) Current Topics in Tumor Cell Physiology and Positron-Emission Tomography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02393-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-02393-8_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13007-9

  • Online ISBN: 978-3-662-02393-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics